White House health advisor and top US infectious diseases expert, Dr Anthony Fauci has revealed that data collected from the Coronavirus drug trial testing with the antiviral drug Remdesivir showed ‘quite good news’ and has set a new standard of care for COVID-19 patients.

According to the study led by the US National Institute of Health, the drug shortens the time it takes for patients to recover by four days on average, and it is the first drug treatment to pass such a strict test against the virus.

Remdesivir, produced by Gilead Sciences was tested in 1,063 hospitalized Coronavirus patients around the world and according to Dr. Anthony Fauci, the drug reduced the time it takes patients to recover by 31%, 11 days on average versus 15 days for those just given usual care.

He said “What it has proven is that a drug can block this virus, this will be the standard of care.”